Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: "Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver
A completed clinical trial examined a swallowing maneuver as a non-pharmacologic approach to inhibit detrusor overactivity in individuals wi…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder
This clinical trial update describes an assessment of autonomic nervous system function before and after anticholinergic treatment in women …
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: SVT-40776 in Patients Suffering From Overactive Bladder Syndrome [Phase 2]
A Phase 2 clinical trial of SVT-40776 for overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Pulsed Electromagnetic Stimulation for Treatment of Overactive Bladder [NA]
Clinical trial update indicates termination of a study evaluating pulsed electromagnetic stimulation for overactive bladder; no results are …
-
CLINICAL_TRIALS trial_result · 2011-06-01Clinical Trial Update: The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects [Phase 1]
Phase 1 study evaluating the effect of fluconazole on the pharmacokinetics of fesoterodine in healthy subjects, sponsored by Pfizer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-01Clinical Trial Update: The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects [Phase 1]
Phase 1 study evaluating whether fesoterodine affects the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
-
FDA approval · 2011-03-31FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Trospium chloride from Glenmark Pharmaceuticals Inc., USA.
-
CLINICAL_TRIALS trial_result · 2011-03-23Clinical Trial Update: Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder [Phase 2]
Pfizer conducted a Phase 2 trial to assess different doses of UK-369,003 in men with overactive bladder; the study status is completed.
-
CLINICAL_TRIALS research · 2011-03-15Clinical Trial Update: Reproducibility Study of Over Active Bladder Symptom Score [OABSS]
This clinical trial update summarizes a reproducibility study of the Overactive Bladder Symptom Score (OABSS) used to measure symptom severi…
-
FDA label_change · 2011-03-10FDA Approved: VESICARE — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for Vesicare (solifenacin succinate) by Astellas Pharma US, Inc., resulting in a label update.
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
A pilot sleep-laboratory study comparing nocturnal bladder physiology in subjects with overactive bladder, insomnia, and healthy controls.
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder. [Phase 2]
This Phase 2 trial assessed the efficacy and safety of botulinum toxin A for refractory overactive bladder and has completed.
-
FDA approval · 2011-02-10FDA Approved: TOVIAZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TOVIAZ (fesoterodine fumarate) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2011-01-31FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for OXYTROL (oxybutynin) from Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2011-01-26Clinical Trial Update: UK Study Assessing Flexible Dose Fesoterodine in Adults [Phase 4]
Pfizer completed a Phase 4 UK study evaluating flexible-dose fesoterodine in adults with overactive bladder; results were posted in January …
-
CLINICAL_TRIALS trial_result · 2011-01-13Clinical Trial Update: A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment
A completed clinical trial evaluated how the Overactive Bladder Symptom Score (OABSS) responds to treatment in individuals with overactive b…
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder. [Phase 3]
Phase 3 trial comparing fesoterodine with tolterodine ER in patients with overactive bladder has completed and results have been posted. The…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Refractory Urge Incontinence and Botox Injections [Phase 3]
A Phase 3 trial evaluating botulinum toxin injections for refractory urge incontinence due to detrusor overactivity was terminated.
-
CLINICAL_TRIALS trial_result · 2010-11-22Clinical Trial Update: Fesoterodine "add-on" Male Overactive Bladder Study [Phase 3]
Phase 3 trial update for fesoterodine as add-on therapy in men with overactive bladder. The study is completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-11-18Clinical Trial Update: Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy
Clinical trial update for patients with overactive bladder treated with Toviaz after failure of previous therapy; study status completed wit…
-
FDA approval · 2010-11-17FDA Approved: TROSPIUM CHLORIDE — Original Application (Padagis US LLC)
FDA approves the original application for trospium chloride (Padagis US LLC) for the treatment of overactive bladder.
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers. [Phase 1]
A Phase 1 bioequivalence study evaluating a single dose of darifenacin 7.5 mg tablets in fed healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2010-10-26Clinical Trial Update: The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder [Phase 1]
Phase 1 clinical trial evaluating the effect of standardized fluid intake in female patients with Overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2010-10-26Clinical Trial Update: A Clinical Study for Magnetic Stimulation of the Posterior Tibial Nerve in Overactive Bladder [NA]
This update notes the completion of a clinical study evaluating magnetic stimulation of the posterior tibial nerve for overactive bladder.
-
CLINICAL_TRIALS trial_result · 2010-10-05Clinical Trial Update: Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life [Phase 4]
A Phase 4 clinical trial evaluating solifenacin (VESIcare) for symptom bother and health-related quality of life in adults with overactive b…